Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase 2 Trial of Donafenib in 131I-Refractory Differentiated Thyroid Cancer

Suzhou Zelgen Biopharmaceuticals Co.,Ltd · 2016
ClinicalTrials.gov · Datasets · License: Public Domain · 2016
Open Source ↗
differentiated thyroid cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 805698
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.